Overview

A Study for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Brain and/or Spinal Cord Conditions

Status:
NOT_YET_RECRUITING

Trial end date:
2025-04-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy and safety of HRS-9231 for Central Nervous System (CNS) Magnetic Resonance Imaging (MRI); to explore the effective dose of HRS-9231 for CNS MRI; and to explore the population pharmacokinetic characteristics of HRS-9231 in CNS MRI subjects

Phase:

PHASE2

Details

Lead Sponsor:

Jiangsu HengRui Medicine Co., Ltd.

Treatments:

gadobutrol